BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24467316)

  • 1. IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases.
    Lal A; Dahiya S; Gonzales M; Hiniker A; Prayson R; Kleinschmidt-DeMasters BK; Perry A
    Brain Pathol; 2014 Jul; 24(4):352-9. PubMed ID: 24467316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoplasmacyte-Rich Meningioma or IgG4-Related Disease: Walking the Thin Line.
    Zaidi A; Chatterjee D; Radotra B; Mohindra S
    Neurol India; 2023; 71(5):1007-1010. PubMed ID: 37929445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
    Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
    Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoplasmacyte-Rich Meningioma With Atypical Angiomatous Feature and an Increased Deposition of IgG4-Positive Plasma Cells: An Unusual Case Report.
    Son HJ; Yu IK; Kim SM
    Int J Surg Pathol; 2018 Feb; 26(1):93-97. PubMed ID: 28862040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of mononuclear cells in meningiomas.
    Bø L; Mørk SJ; Nyland H
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):548-58. PubMed ID: 1488087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas.
    Rapp C; Dettling S; Liu F; Ull AT; Warta R; Jungk C; Roesch S; Mock A; Sahm F; Schmidt M; Jungwirth G; Zweckberger K; Lamszus K; Gousias K; Kessler AF; Grabe N; Loehr M; Ketter R; Urbschat S; Senft C; Westphal M; Abdollahi A; Debus J; von Deimling A; Unterberg A; Simon M; Herold-Mende CC
    Clin Cancer Res; 2019 Sep; 25(17):5260-5270. PubMed ID: 31227506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell (Zoon) balanitis: another inflammatory disorder that can be rich in IgG4+ plasma cells.
    Aggarwal N; Parwani AV; Ho J; Cook JR; Swerdlow SH
    Am J Surg Pathol; 2014 Oct; 38(10):1437-43. PubMed ID: 25216321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas.
    Takahashi JA; Ueba T; Hashimoto N; Nakashima Y; Katsuki N
    Surg Neurol; 2004 Feb; 61(2):149-55; discussion 155-6. PubMed ID: 14751627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients.
    Ülgen E; Bektaşoğlu PK; Sav MA; Can Ö; Danyeli AE; Hızal DB; Pamir MN; Özduman K
    World Neurosurg; 2019 Mar; 123():e520-e535. PubMed ID: 30503291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
    Puripat N; Loharamtaweethong K
    Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular lymphoplasmacyte-rich meningioma: a case report.
    Wang YB; Wang WJ; Xu SB; Xu BF; Yu Y; Ma H; Zhang XF
    Turk Neurosurg; 2014; 24(6):958-62. PubMed ID: 25448216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and vascular characteristics in cavernous sinus meningioma.
    Kosugi K; Tamura R; Ohara K; Morimoto Y; Kuranari Y; Oishi Y; Yoshida K; Toda M
    J Clin Neurosci; 2019 Sep; 67():198-203. PubMed ID: 31213381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical study of the cellular immune response in meningiomas.
    Rossi ML; Cruz Sanchez F; Hughes JT; Esiri MM; Coakham HB
    J Clin Pathol; 1988 Mar; 41(3):314-9. PubMed ID: 3258871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Correlation Between Immunohistochemical Expression of SPARC and Invasion in Different Grades of Meningiomas.
    Rooprai HK; Martin AJ; King A; Appadu UD; Gullan RW; Thomas NWM; Pilkington GJ
    Anticancer Res; 2020 Jun; 40(6):3081-3089. PubMed ID: 32487602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of a rare case of atypical lymphoplasmacyte-rich meningioma in the tentorium mimicking idiopathic hypertrophic pachymeningitis.
    Cha YJ; Lee SK; Chang JH; Kim SH
    Brain Tumor Pathol; 2016 Jul; 33(3):216-21. PubMed ID: 26902101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clivus Inflammatory Pseudotumor Associated with Immunoglobulin G4-Related Disease.
    Tang H; Ding G; Xiong J; Zhu H; Hua L; Xie Q; Gong Y
    World Neurosurg; 2018 Oct; 118():71-74. PubMed ID: 29966794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
    Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
    J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipomatous metaplasia occurring within meningiomas--two case reports.
    Singh A; Sharma KC
    Indian J Pathol Microbiol; 2005 Oct; 48(4):477-8. PubMed ID: 16366099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.